Indications that paraoxonase-1 contributes to plasma high density lipoprotein levels in familial hypercholesterolemia
HDL-associated paraoxonase type 1 (PON1) can protect LDL and HDL against oxidative modification in vitro and therefore may protect against cardiovascular disease. We investigated the effects of PON1 levels, activity, and genetic variation on high density lipoprotein-cholesterol (HDL-C) levels, circu...
Main Authors: | Thomas M. van Himbergen, Mark Roest, Jacqueline de Graaf, Eugène H.J.M. Jansen, Hiroaki Hattori, John J.P. Kastelein, Hieronymus A.M. Voorbij, Anton F.H. Stalenhoef, Lambertus J.H. van Tits |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2005-03-01
|
Series: | Journal of Lipid Research |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S0022227520340281 |
Similar Items
-
Decreased adiponectin levels in familial combined hyperlipidemia patients contribute to the atherogenic lipid profile
by: Gerly M. van der Vleuten, et al.
Published: (2005-11-01) -
Long term stability of paraoxonase-1 and high-density lipoprotein in human serum
by: Beekhof Piet K, et al.
Published: (2012-05-01) -
Relative risk for cardiovascular atherosclerotic events after smoking cessation: 6–9 years excess risk in individuals with familial hypercholesterolemia
by: Kastelein John JP, et al.
Published: (2006-10-01) -
Paraoxonase 1 R/Q alleles are associated with differential accumulation of saturated versus 20:5n3 fatty acid in human adipose tissue
by: Alexandros Zafiropoulos, et al.
Published: (2010-07-01) -
6.6 WAIST CIRCUMFERENCE IS A BETTER PREDICTOR OF SUBCLINICAL ATHEROSCLEROSIS THAN ADIPONECTIN LEVEL
by: S. Holewijn, et al.
Published: (2009-12-01)